CoMeta™ Life Science adds pharmaceutical Litagion® agent profiles to CoMeta focusing on evaluating the liability that could arise from a manufacturer’s failure to warn physicians regarding the risk of specific…
read more
Separating the Rumors from the Science: Rivaroxaban
https://www.praedicat.com/wp-content/themes/fildisi/images/empty/thumbnail.jpg
150
150
Sheryll Mangahas
https://www.praedicat.com/wp-content/uploads/2018/06/sheryll-mangahas-600x400-150x150.jpg